Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury

Phase 1/2 Unknown 40 enrolled Affiliated Hospital to Academy of Military Medical Sciences Ivy Institute of Stem Cells Co. Ltd · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

Phase I-II Clinical Trial-Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with paraquat poisoning induced lung injury, randomized,single blind, controlled prospective study.

Timeline

Start: 2015-05
Primary completion: 2017-05
Completion: 2017-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	human umbilical cord mesenchymal stem cells	Cell therapy	500000 cells/kg	Intravenous

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury

Summary

Timeline

Drugs

Indications